Isoindazole compound
    3.
    发明授权
    Isoindazole compound 失效
    异吲唑化合物

    公开(公告)号:US5387684A

    公开(公告)日:1995-02-07

    申请号:US142447

    申请日:1994-01-24

    摘要: An isoindazole compound of the formula (1) or a salt thereof; a method for the production thereof; and pharmaceutical use of the compound and a salt thereof, particularly as an angiotensin II antagonist and as an agent for the prophylaxis and treatment of circulatory diseases (particularly hypertension and heart failure); ##STR1## wherein Q is a heterocyclic derivative of the formula (2) or (3) ##STR2## wherein other symbols of the above formulas are as defined in the Specification. The compound and its salt show superior angiotensin II antagonism and are low toxic. Accordingly, they are useful as angiotensin II antagonists for the treatment or prophylaxis of angiotensin II-mediated diseases such as circulatory diseases of hypertension (e.g. essential hypertension, renal hypertension) and heart failure.

    摘要翻译: 式(1)的异吲唑化合物或其盐; 一种生产它的方法; 以及化合物及其盐,特别是作为血管紧张素II拮抗剂和预防和治疗循环系统疾病(特别是高血压和心力衰竭)的药物的药物用途; (1)其中Q是式(2)或(3)的杂环衍生物。其中上述式的其它符号如本说明书中所定义。 该化合物及其盐显示出优异的血管紧张素II拮抗作用,毒性低。 因此,它们可用作血管紧张素II拮抗剂,用于治疗或预防血管紧张素II介导的疾病,例如高血压的循环系统疾病(例如原发性高血压,肾性高血压)和心力衰竭。